Cite
APA Citation
Rosenthal, E. M., Hall, E. W., Rosenberg, E. S., Harris, A., Nelson, N. P., & Schillie, S. (2021). corrigendum to "Assessing the cost-utility of preferentially administering Heplisav-B vaccine to certain populations" [Vaccine 38(51) (2020) 8206–8215]. Vaccine, 39(36), 5231–. http://access.bl.uk/ark:/81055/vdc_100139917135.0x000048